glp 1 agonists moa Trends in the Development of GLP-1 Receptor Glucagon-like peptide 1 receptor agonists:
Description
Am J Respir Crit Care Med
Though all of the studies focused on the same primary endpoint, hospitalizations due to heart failure, the results differed across studies
Some conditions - even molecular mimicry in mix
While oral GLP1s introduce greater upstream complexity and higher costs of goods, these realities are not always fully reflected in how oral therapies are perceived in the market
27 Also, studies have concluded that it is very difficult and expensive to treat patients to an HbA1c level of less than 7%
